35.28
price up icon0.09%   0.03
after-market アフターアワーズ: 35.28
loading
前日終値:
$35.25
開ける:
$35.54
24時間の取引高:
4.01M
Relative Volume:
1.01
時価総額:
$15.25B
収益:
$2.31B
当期純損益:
$1.66B
株価収益率:
15.34
EPS:
2.3
ネットキャッシュフロー:
$827.02M
1週間 パフォーマンス:
-2.65%
1か月 パフォーマンス:
-1.95%
6か月 パフォーマンス:
+13.33%
1年 パフォーマンス:
+24.71%
1日の値動き範囲:
Value
$34.96
$35.54
1週間の範囲:
Value
$34.63
$36.44
52週間の値動き範囲:
Value
$24.05
$38.00

Royalty Pharma Plc Stock (RPRX) Company Profile

Name
名前
Royalty Pharma Plc
Name
セクター
Healthcare (1147)
Name
電話
(212) 883-0200
Name
住所
110 EAST 59TH STREET, NEW YORK, NY
Name
職員
99
Name
Twitter
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
RPRX's Discussions on Twitter

RPRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RPRX
Royalty Pharma Plc
35.28 15.24B 2.31B 1.66B 827.02M 2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-30 開始されました Goldman Buy
2025-05-16 開始されました Morgan Stanley Overweight
2024-06-03 ダウングレード UBS Buy → Neutral
2022-06-14 再開されました UBS Buy
2022-05-13 開始されました Scotiabank Sector Outperform
2022-04-27 開始されました Goldman Buy
2022-04-14 アップグレード JP Morgan Neutral → Overweight
2022-04-06 再開されました Morgan Stanley Overweight
2021-10-29 アップグレード Citigroup Neutral → Buy
2021-07-30 開始されました Tigress Financial Buy
2020-11-09 アップグレード UBS Neutral → Buy
2020-07-14 開始されました Evercore ISI In-line
2020-07-13 開始されました BofA Securities Buy
2020-07-13 開始されました Citigroup Neutral
2020-07-13 開始されました Cowen Outperform
2020-07-13 開始されました Goldman Neutral
2020-07-13 開始されました JP Morgan Neutral
2020-07-13 開始されました Morgan Stanley Equal-Weight
2020-07-13 開始されました SunTrust Buy
2020-07-13 開始されました UBS Neutral
すべてを表示

Royalty Pharma Plc (RPRX) 最新ニュース

pulisher
Sep 30, 2025

Royalty Pharma : Q3 2025 Pre-Quarterly Results Communication - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

Goldman Sachs Initiates Coverage of Royalty Pharma (RPRX) with Buy Recommendation - Nasdaq

Sep 30, 2025
pulisher
Sep 30, 2025

Royalty Pharma plc Stock Analysis and ForecastPrice Action Analysis & High Profit Investment Ideas - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Goldman Sachs initiates Royalty Pharma stock with Buy rating, $42 target - Investing.com UK

Sep 30, 2025
pulisher
Sep 30, 2025

Goldman Sachs Starts Royalty Pharma (RPRX) at Buy, PT $42 - StreetInsider

Sep 30, 2025
pulisher
Sep 30, 2025

Why Royalty Pharma plc stock is a must watch in 2025Market Growth Review & High Conviction Investment Ideas - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Royalty Pharma : Bernstein Healthcare Forum Transcript - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Royalty Pharma appoints Ted Love as lead independent director - Investing.com

Sep 29, 2025
pulisher
Sep 29, 2025

Royalty Pharma names Dr. Ted Love as lead independent director - StreetInsider

Sep 29, 2025
pulisher
Sep 29, 2025

Biotech Leader Ted Love Takes Key Board Role at Royalty Pharma, Bringing BIO Leadership Experience - Stock Titan

Sep 29, 2025
pulisher
Sep 29, 2025

What candlestick patterns are forming on Royalty Pharma plcEarnings Trend Report & Stepwise Trade Execution Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Will Royalty Pharma plc stock see PE expansion2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Overbrook Management Corp Trims Position in Royalty Pharma PLC $RPRX - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Is Royalty Pharma plc stock a smart buy before Fed meetingJuly 2025 Volume & Risk Managed Investment Signals - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Understanding Royalty Pharma plc’s price movementGap Up & Breakout Confirmation Trade Signals - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Is Royalty Pharma plc RPD a good long term investmentStock Liquidity Analysis & Fast Growing Investment Plans - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What analysts say about Royalty Pharma plc RPD stockDividend Reinvestment Plans & Free Tools to Monitor Market Corrections - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Why Royalty Pharma plc (RPD) stock could rally strongly2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Assessing Royalty Pharma (RPRX): Is the Recent Outperformance Reflected in Its Current Valuation? - Yahoo Finance

Sep 27, 2025
pulisher
Sep 27, 2025

Bank Pictet & Cie Europe AG Cuts Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Sep 27, 2025
pulisher
Sep 25, 2025

Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - 富途牛牛

Sep 25, 2025
pulisher
Sep 25, 2025

Ruffer LLP Makes New $6.41 Million Investment in Royalty Pharma PLC $RPRX - MarketBeat

Sep 25, 2025
pulisher
Sep 23, 2025

Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth - Insider Monkey

Sep 23, 2025
pulisher
Sep 23, 2025

Wedge Capital Management L L P NC Grows Position in Royalty Pharma PLC $RPRX - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Royalty Pharma at Bernstein Forum: Strategic Insights on Growth - Investing.com South Africa

Sep 23, 2025
pulisher
Sep 23, 2025

Royalty Pharma at Bernstein Forum: Strategic Insights on Growth By Investing.com - Investing.com UK

Sep 23, 2025
pulisher
Sep 23, 2025

Transcript : Royalty Pharma plc Presents at Bernstein Insights - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

Mn Services Vermogensbeheer B.V. Acquires Shares of 67,000 Royalty Pharma PLC $RPRX - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood? - MSN

Sep 22, 2025
pulisher
Sep 22, 2025

Royalty Pharma PLC $RPRX Shares Sold by Ridgewood Investments LLC - MarketBeat

Sep 22, 2025
pulisher
Sep 20, 2025

Strs Ohio Invests $1.89 Million in Royalty Pharma PLC $RPRX - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum - The Manila Times

Sep 20, 2025
pulisher
Sep 19, 2025

Pacific Capital Partners Ltd Sells 77,500 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Sell Signal: Does HAIN align with a passive investing strategyPortfolio Gains Report & Fast Momentum Entry Tips - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Analyst Downgrade: Why is Royalty Pharma plc stock going downJuly 2025 Trends & AI Enhanced Trading Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today - Sahm

Sep 19, 2025
pulisher
Sep 19, 2025

Leading Biopharma Royalty Investor Royalty Pharma Featured at Bernstein Healthcare Forum 2025 - Stock Titan

Sep 19, 2025
pulisher
Sep 19, 2025

Layoff Watch: Will Royalty Pharma plc benefit from rate cutsWeekly Trend Recap & Stock Market Timing Techniques - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 226,048 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Market Outlook: Should I buy Royalty Pharma plc stock now2025 Market Overview & Daily Entry Point Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Royalty Pharma (NASDAQ:RPRX) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Nasdaq Moves: What are the analyst revisions for GCLWWIs Royalty Pharma plc stock a good investment in YEARJuly 2025 Macro Moves & Verified Chart Pattern Trade Signals - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Royalty Pharma’s $2 Billion Debt Offering Could Be a Game Changer for RPRX - simplywall.st

Sep 17, 2025
pulisher
Sep 17, 2025

TD Cowen Maintains a Buy on Royalty Pharma (RPRX) - Insider Monkey

Sep 17, 2025
pulisher
Sep 17, 2025

Royalty Pharma Plc Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo

Sep 17, 2025
pulisher
Sep 17, 2025

Syndax, Royalty Pharma enter into $350M royalty funding deal - MSN

Sep 17, 2025
pulisher
Sep 17, 2025

12 Affordable Biotech Stocks to Invest In Now - Insider Monkey

Sep 17, 2025
pulisher
Sep 16, 2025

Empowered Funds LLC Buys New Shares in Royalty Pharma PLC $RPRX - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Royalty Pharma Completes $2 Billion Senior Notes Offering - TipRanks

Sep 16, 2025

Royalty Pharma Plc (RPRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
大文字化:     |  ボリューム (24 時間):